Biofrontera Inc. (BFRI)
After hours:
| Previous Close | 1.1200 |
| Open | 1.0900 |
| Bid | 1.2000 x 100 |
| Ask | 1.2000 x 100 |
| Day's Range | 1.0817 - 1.2550 |
| 52 Week Range | 0.6100 - 12.5000 |
| Volume | |
| Avg. Volume | 53,788 |
| Market Cap | 6.311M |
| Beta (5Y Monthly) | 0.45 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.3000 |
| Earnings Date | Aug 11, 2024 - Aug 26, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.00 |
Simply Wall St.When Will Biofrontera Inc. (NASDAQ:BFRI) Become Profitable?
We feel now is a pretty good time to analyse Biofrontera Inc.'s ( NASDAQ:BFRI ) business as it appears the company may...
GlobeNewswireBiofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp
The RhodoLED XL is approved by the FDA in combination with Ameluz® (aminolevulinic acid hydrochloride) topical gel, 10% for photodynamic therapy (PDT) of actinic keratoses of mild-to-moderate severity on the face and scalpBiofrontera launched the commercial distribution of the RhodoLED XL on June 10, 2024, shipping the first three machines within 1 week of launch WOBURN, MA, June 24, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI), a biopharmaceutical company specializing in the commerc
ACCESSWIREBiofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
Conference call begins at 10:00 a.m. Eastern time on Thursday, May 16, 2024 WOBURN, MA / ACCESSWIRE / May 15, 2024 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic ...
